External Defibrillators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.92 Billion
CAGR (2026-2031)	7.54%
Fastest Growing Segment	Fully Automated External Defibrillator
Largest Market	North America
Market Size (2031)	USD 2.97 Billion

Market Overview

The Global External Defibrillators Market will grow from USD 1.92 Billion in 2025 to USD 2.97 Billion by 2031 at a 7.54% CAGR. External defibrillators are therapeutic medical devices designed to analyze cardiac rhythms and deliver a controlled electrical shock to restore normal sinus rhythm in patients experiencing sudden cardiac arrest. The market for these devices is primarily supported by the rising global prevalence of cardiovascular diseases and an aging demographic increasingly susceptible to cardiac events. Furthermore, stringent government mandates requiring the installation of automated units in public spaces and commercial establishments serve as a fundamental driver for widespread adoption, ensuring immediate intervention capabilities in high-traffic areas.

However, the market faces a substantial challenge regarding the alignment of device availability with the actual location of cardiac emergencies. According to the American Heart Association, in 2024, statistical data indicated that 72.1% of adult out-of-hospital cardiac arrests occurred at a private residence. This discrepancy highlights a critical gap in market penetration, as current public access models do not adequately address the majority of incidents that take place in home settings, thereby impeding the maximization of survival outcomes and sector expansion.

Key Market Drivers

The escalating prevalence of sudden cardiac arrest and cardiovascular pathologies serves as the primary catalyst for the external defibrillators market. As incidence rates of arrhythmias and ischemic heart conditions rise globally, healthcare systems and private entities are prioritizing the procurement of life-saving intervention tools to manage patient outcomes effectively. This demand is directly correlated with mortality trends that highlight the critical need for rapid defibrillation capabilities in both clinical and pre-hospital environments. According to the World Heart Federation, May 2024, in the 'World Heart Report 2024', deaths from cardiovascular disease have risen significantly, reaching 20.5 million deaths globally in the most recent comprehensive analysis, driving the urgency for therapeutic interventions. Consequently, clinical settings and high-risk environments are intensifying their equipment acquisition strategies to mitigate these rising fatality metrics.

Simultaneously, the expansion of government mandates for public access defibrillator deployment acts as a regulatory engine for market growth. Legislative bodies are increasingly establishing grant programs and legal requirements to ensure automated external defibrillators are available in community hubs, thereby reducing response times during emergencies. According to the Department of Health and Social Care, January 2024, in the 'Community Automated External Defibrillators Fund', community organizations were invited to bid for a share of 1 million GBP to install life-saving devices in public spaces across England. This regulatory push is complemented by substantial private sector investment aimed at enhancing device technology and distribution networks. According to Avive Solutions, in 2024, the company secured 56.5 million USD in growth capital to accelerate the commercial expansion of their connected device ecosystem, reflecting the robust financial confidence in this medical technology sector.

Download Free Sample Report

Key Market Challenges

The Global External Defibrillators Market faces a critical impediment regarding the disparity between device accessibility and the actual settings of cardiac emergencies. While regulatory mandates successfully drive installation in commercial and public venues, the residential sector remains significantly underpenetrated. This misalignment restricts the total addressable market, as the industry continues to saturate lower-incidence public locations while the high-risk home segment remains largely unaddressed due to cost barriers and a lack of legislative requirements for private properties.

This gap in availability severely limits the technology's effectiveness in improving survival statistics, which fundamentally dampens consumer confidence and adoption urgency. According to the American Heart Association, in 2024, the survival rate for out-of-hospital cardiac arrest was approximately 10 percent. This low survival figure underscores the inefficiency of current public access models in addressing the majority of incidents. Consequently, the market struggles to transition the perception of defibrillators from institutional medical equipment to essential household safety devices, thereby hampering the sector's ability to maximize both clinical outcomes and revenue potential.

Key Market Trends

The Integration with Mobile Applications for Rapid Device Localization and Crowdsourcing is fundamentally reshaping the deployment strategies of external defibrillators. This trend addresses the visibility gap where bystanders cannot locate nearby devices during emergencies, driving the creation of digital registries synchronized with emergency medical services. By leveraging smartphone technology and connected networks, stakeholders are ensuring that existing inventory is mapped and accessible to dispatchers and lay rescuers, thereby maximizing the utility of deployed assets. According to the British Heart Foundation, July 2025, in the 'BHF reveals the country's defibrillator deserts' report, there are over 110,000 defibrillators registered on The Circuit, the national defibrillator network, illustrating the scale of digital integration aimed at optimizing device retrieval times.

Simultaneously, the Development of Next-Generation Compact and Portable Personal AEDs is gaining traction as manufacturers target the underserved residential market. Recognizing that public access programs often fail to reach victims in private settings, industry players are engineering ultra-portable, user-friendly units designed specifically for layperson ownership and immediate home deployment. This shift is further accelerated by clinical data indicating that reliance solely on public infrastructure leaves a significant intervention void. According to the Sudden Cardiac Arrest Foundation, in the 'Latest Statistics' summary published in January 2025, only 12.6% of patients who arrested in public had a bystander-applied AED, reinforcing the urgent market imperative for personal-grade devices that ensure immediate availability regardless of location.

Segmental Insights

The Fully Automated External Defibrillator segment represents the fastest growing category within the Global External Defibrillators Market due to rising adoption in public access settings. This growth is largely attributed to the device's operational design, which allows lay responders to administer treatment without manual intervention, significantly reducing the risk of user error during emergencies. Additionally, widespread initiatives by entities such as the American Heart Association to combat sudden cardiac arrest have spurred mandates for these devices in schools, airports, and corporate offices. Consequently, the focus on improved accessibility and ease of use continues to drive substantial market demand.

Regional Insights

North America maintains a dominant position in the global external defibrillators market, driven by the high prevalence of cardiovascular diseases and sudden cardiac arrests. This leadership is reinforced by supportive healthcare infrastructure and favorable reimbursement structures that facilitate equipment procurement. Additionally, extensive public access defibrillation programs promoted by the American Heart Association increase device accessibility in public spaces. The market further benefits from the presence of major manufacturers and a defined regulatory framework under the U.S. Food and Drug Administration, ensuring the consistent availability and adoption of these medical devices throughout the region.

Recent Developments

• In September 2025, ZOLL Medical Corporation announced that it received Premarket Approval from the U.S. FDA for the Zenix monitor/defibrillator. The device allows healthcare professionals in hospital and emergency medical services settings to access essential functions through a touchscreen interface. It incorporates proprietary technologies that provide real-time feedback on ventilation and cardiopulmonary resuscitation (CPR) quality. The system was engineered to support clinical decision-making by displaying relevant patient data and facilitating automated workflows. This regulatory clearance expanded the company's portfolio of critical care technologies available in the United States and Canada.
• In May 2025, Element Science received Premarket Approval from the U.S. Food and Drug Administration (FDA) for the Jewel Patch Wearable Cardioverter Defibrillator (Patch-WCD). This prescription device is designed for patients with a temporarily elevated risk of sudden cardiac arrest and monitors their heart rhythm continuously. The water-resistant wearable utilizes machine learning algorithms to detect life-threatening arrhythmias and deliver a therapeutic shock if necessary. The approval marked a significant regulatory milestone for the company, introducing a low-profile, unobtrusive option for therapeutic monitoring that integrates into patients' daily activities without requiring manual intervention.
• In October 2024, Avive Solutions announced a strategic collaboration with RapidSOS to launch a new feature called QuickRescue. This technology enables the company’s connected automated external defibrillators (AEDs) to automatically transmit real-time incident data directly to 911 telecommunicators when a device is activated. The integration allows public safety answering points to receive critical information, including the device's location and status, during the initial moments of a sudden cardiac arrest. This partnership was established to bridge the communication gap between bystanders and emergency services, aiming to improve response times and survival rates.
• In June 2024, Stryker launched the LIFEPAK 35 monitor/defibrillator, a new device designed for emergency responders and healthcare professionals. The platform was developed after extensive research and customer feedback to address workflow challenges and staff shortages in critical care settings. It features a slim, lightweight design and a large, intuitive touchscreen that allows for a customizable clinical experience. The device also supports advanced patient care through connected capabilities that enable secure access to patient data. This launch aimed to streamline operations and reduce the cognitive burden on caregivers during emergency events.

Key Market Players

• Koninklijke Philips N.V.
• Stryker Corporation
• Zoll Medical Corporation
• Nihon Kohden Corporation
• ProgettiSrl
• Schiller AG
• MS Westfalia GmbH
• Bexen Cardio
• Silverline Meditech Pvt. Ltd.
• Mediana Co., Ltd.

By Product	By End user	By Region
Manual External Defibrillators Automated External Defibrillators Wearable Cardioverter Defibrillators	Hospitals & Clinics Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global External Defibrillators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• External Defibrillators Market, By Product:

• Manual External Defibrillators
• Automated External Defibrillators
• Wearable Cardioverter Defibrillators

• External Defibrillators Market, By End user:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

• External Defibrillators Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE